-
1
-
-
47649091099
-
A new serum type system in man: The Lp system
-
Berg K: A new serum type system in man: the Lp system. Acta Pathol Microbiol Scand 1963; 59:362-82
-
(1963)
Acta Pathol Microbiol Scand
, vol.59
, pp. 362-382
-
-
Berg, K.1
-
2
-
-
0023636242
-
cDNA sequence of human apolipoprotein(a) is homologous to plasminogen
-
McLean J, Tomlinson J, Kuang WJ, et al: cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 1987; 330:132-7
-
(1987)
Nature
, vol.330
, pp. 132-137
-
-
McLean, J.1
Tomlinson, J.2
Kuang, W.J.3
-
5
-
-
0142058981
-
Apolipoprotein (a) and cortical cerebral infarction
-
Yingdong Z, Xiuling L: Apolipoprotein (a) and cortical cerebral infarction. Chin Med Sci J. 1999; 14:249-54
-
(1999)
Chin Med Sci J
, vol.14
, pp. 249-254
-
-
Yingdong, Z.1
Xiuling, L.2
-
6
-
-
0030794879
-
Lipoprotein (a) and its relationship to risk factors and severity of atherosclerotic peripheral vascular disease
-
Cheng SW, Ting AC, Wong J: Lipoprotein (a) and its relationship to risk factors and severity of atherosclerotic peripheral vascular disease. Eur J Vasc Endovasc Surg 1997; 17:17-23
-
(1997)
Eur J Vasc Endovasc Surg
, vol.17
, pp. 17-23
-
-
Cheng, S.W.1
Ting, A.C.2
Wong, J.3
-
7
-
-
0034609562
-
Lipoprotein a and coronary heart disease: A meta-analysis of prospective studies
-
Danesh J, Collins R, Peto R: Lipoprotein a and coronary heart disease: a meta-analysis of prospective studies. Circulation 2000; 102:1082-5
-
(2000)
Circulation
, vol.102
, pp. 1082-1085
-
-
Danesh, J.1
Collins, R.2
Peto, R.3
-
8
-
-
0035892139
-
Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: A novel link between lipoproteins and thrombosis
-
Caplice NM, Panetta C, Peterson TE, et al: Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis. Blood 2001; 98:2980-7
-
(2001)
Blood
, vol.98
, pp. 2980-2987
-
-
Caplice, N.M.1
Panetta, C.2
Peterson, T.E.3
-
9
-
-
0028215089
-
Lipoproteins inhibit the secretion of tissue plasminogen activator from human endothelial cells
-
Levin EG, Miles LA, Fless GM, Scanu AM, Baynham P, Curtiss LK, Plow EF. Lipoproteins inhibit the secretion of tissue plasminogen activator from human endothelial cells. Arterioscler Thromb 1994; 14:438-42
-
(1994)
Arterioscler Thromb
, vol.14
, pp. 438-442
-
-
Levin, E.G.1
Miles, L.A.2
Fless, G.M.3
Scanu, A.M.4
Baynham, P.5
Curtiss, L.K.6
Plow, E.F.7
-
10
-
-
0031043615
-
Oxidative modification enhances lipoprotein(a)-induced overproduction of plasminogen activator inhibitor-I in cultured vascular endothelial cells
-
Ren S, Man RY, Angel A, Shen GX: Oxidative modification enhances lipoprotein(a)-induced overproduction of plasminogen activator inhibitor-I in cultured vascular endothelial cells. Atherosclerosis 1997; 128:1-10
-
(1997)
Atherosclerosis
, vol.128
, pp. 1-10
-
-
Ren, S.1
Man, R.Y.2
Angel, A.3
Shen, G.X.4
-
11
-
-
0142120306
-
Lipoprotein (a) downregulates lysosomal acid lipase and induces interleukin-6 in human blood monocytes
-
Buechler C, Ullrich H, Aslanidis C, et al: Lipoprotein (a) downregulates lysosomal acid lipase and induces interleukin-6 in human blood monocytes. Biochim Biophys Acta 2003; 1642:25-31
-
(2003)
Biochim Biophys Acta
, vol.1642
, pp. 25-31
-
-
Buechler, C.1
Ullrich, H.2
Aslanidis, C.3
-
12
-
-
0042510743
-
Inflammatory reactions in the pathogenesis of atherosclerosis
-
Fan J, Watanabe T: Inflammatory reactions in the pathogenesis of atherosclerosis. J Atheroscler Thromb 2003; 10:63-71
-
(2003)
J Atheroscler Thromb
, vol.10
, pp. 63-71
-
-
Fan, J.1
Watanabe, T.2
-
13
-
-
0041472508
-
Circulating transforming growth factor-beta1, lipoprotein(a) and cellular adhesion molecules in angiographically assessed coronary artery disease
-
Bogavac-Stanojevic N, Djurovic S, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V, Kalimanovska-Ostric D: Circulating transforming growth factor-beta1, lipoprotein(a) and cellular adhesion molecules in angiographically assessed coronary artery disease. Clin Chem Lab Med 2003; 41:893-8
-
(2003)
Clin Chem Lab Med
, vol.41
, pp. 893-898
-
-
Bogavac-Stanojevic, N.1
Djurovic, S.2
Jelic-Ivanovic, Z.3
Spasojevic-Kalimanovska, V.4
Kalimanovska-Ostric, D.5
-
14
-
-
0027480741
-
Insoluble complex formation of lipoprotein(a) with low density lipoprotein in the presence of calcium ions
-
Yashiro A, O'Neil J, Hoff HF: Insoluble complex formation of lipoprotein(a) with low density lipoprotein in the presence of calcium ions. J Biol Chem 1993; 268:4709-15
-
(1993)
J Biol Chem
, vol.268
, pp. 4709-4715
-
-
Yashiro, A.1
O'Neil, J.2
Hoff, H.F.3
-
15
-
-
0038223871
-
Türk yetişkinleri için kullanilmaya elverişli bir koroner risk puanlamasi
-
Onat A. Türk yetişkinleri için kullanilmaya elverişli bir koroner risk puanlamasi. Türk Kardiyol Dern Arş 2002; 30:604-11
-
(2002)
Türk Kardiyol Dern Arş
, vol.30
, pp. 604-611
-
-
Onat, A.1
-
16
-
-
0015348189
-
Estimation of the concentration of low-density-lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
-
Friedewald WT, Levy J, Fredrickson DS: Estimation of the concentration of low-density-lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499-509
-
(1972)
Clin Chem
, vol.18
, pp. 499-509
-
-
Friedewald, W.T.1
Levy, J.2
Fredrickson, D.S.3
-
17
-
-
0003575082
-
-
Geneva, WHO
-
Rose G, Blackburn H, Gillum RF, Prineas RJ: Cardiovascular Survey Methods, 2nd edn. Geneva, WHO, 1982; 124-127
-
(1982)
Cardiovascular Survey Methods, 2nd Edn.
, pp. 124-127
-
-
Rose, G.1
Blackburn, H.2
Gillum, R.F.3
Prineas, R.J.4
-
18
-
-
0035003040
-
Risk factors and cardiovascular disease in Turkey
-
Onat A: Risk factors and cardiovascular disease in Turkey. Atherosclerosis 2001; 156:1-10
-
(2001)
Atherosclerosis
, vol.156
, pp. 1-10
-
-
Onat, A.1
-
19
-
-
0035897696
-
Executive Summary of the third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
-
Executive Summary of the third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285:2486-97
-
(2001)
JAMA
, vol.285
, pp. 2486-2497
-
-
-
20
-
-
0030635582
-
American Diabetes Association: Clinical practice recommendations
-
American Diabetes Association: Clinical practice recommendations. Diabetes Care 1997; 20:S1-S70
-
(1997)
Diabetes Care
, vol.20
-
-
-
21
-
-
0028986017
-
Turkish Heart Study: Lipids, lipoproteins, and apolipoproteins
-
Mahley RW, Palaoǧlu KE, Atak Z, et al: Turkish Heart Study: lipids, lipoproteins, and apolipoproteins. J Lipid Res 1995; 36:839-859
-
(1995)
J Lipid Res
, vol.36
, pp. 839-859
-
-
Mahley, R.W.1
Palaoǧlu, K.E.2
Atak, Z.3
-
22
-
-
1642354893
-
Lp(a) levels in men with coronary artey occlusion and healthy male controls
-
Hergenç G, Özsüllü T, Çetinalp P, Beşoluk Ş, Sönmez B: Lp(a) levels in men with coronary artey occlusion and healthy male controls. Biochem Soc Trans 1999; 27:A1222
-
(1999)
Biochem Soc Trans
, vol.27
-
-
Hergenç, G.1
Özsüllü, T.2
Çetinalp, P.3
Beşoluk, Ş.4
Sönmez, B.5
-
23
-
-
0032824730
-
The levels of lipids, lipoproteins and apolipoproteins in healthy people in the central region of the Black Sea
-
Adam B, Talu C, Bedir A, Alvur M, Sagkan O: The levels of lipids, lipoproteins and apolipoproteins in healthy people in the central region of the Black Sea. Jpn Heart J 1999; 40:427-34
-
(1999)
Jpn Heart J
, vol.40
, pp. 427-434
-
-
Adam, B.1
Talu, C.2
Bedir, A.3
Alvur, M.4
Sagkan, O.5
-
24
-
-
0028967550
-
Evaluation of lipoprotein(a) [Lp(a)] as a risk factor for coronary artery disease in the Turkish population
-
Örem A, Deǧer O, Kulan K, Önder E, Kiran E, Uzunosmanoǧlu D: Evaluation of lipoprotein(a) [Lp(a)] as a risk factor for coronary artery disease in the Turkish population. Clin Biochem 1995; 28:171-3
-
(1995)
Clin Biochem
, vol.28
, pp. 171-173
-
-
Örem, A.1
Deǧer, O.2
Kulan, K.3
Önder, E.4
Kiran, E.5
Uzunosmanoǧlu, D.6
-
25
-
-
0242331117
-
Report of the National Heart, Lung, and Blood Institute workshop on lipoprotein (a) and cardiovascular disease: Recent advances and future directions
-
Marcovina SM, Koschinsky ML, Albers JJ, Skarlatos S. Report of the National Heart, Lung, and Blood Institute workshop on lipoprotein (a) and cardiovascular disease: recent advances and future directions. Clin Chem 2003; 49:1785-96
-
(2003)
Clin Chem
, vol.49
, pp. 1785-1796
-
-
Marcovina, S.M.1
Koschinsky, M.L.2
Albers, J.J.3
Skarlatos, S.4
-
26
-
-
0027965819
-
The relationship between serum lipoprotein(a) and insulinemia in healthy nondiabetic adult men
-
Duell PB, Hagemenas F, Connor WE: The relationship between serum lipoprotein(a) and insulinemia in healthy nondiabetic adult men. Diabetes Care. 1994; 17:1135-40
-
(1994)
Diabetes Care
, vol.17
, pp. 1135-1140
-
-
Duell, P.B.1
Hagemenas, F.2
Connor, W.E.3
-
27
-
-
0026619419
-
Lipoprotein (a) concentrations in Mexican Americans and non-Hispanic whites: The san Antonio Herat Study
-
Haffner SM, Gruber KK, Morales PA, et al: Lipoprotein (a) concentrations in Mexican Americans and non-Hispanic whites: the san Antonio Herat Study. Am J Epidemiol 1992; 136:1061-8
-
(1992)
Am J Epidemiol
, vol.136
, pp. 1061-1068
-
-
Haffner, S.M.1
Gruber, K.K.2
Morales, P.A.3
-
28
-
-
0030744611
-
Serum insulin and lipoprotein(a) concentrations
-
Inoue K, Nago N, Matsuo H, et al: Serum insulin and lipoprotein(a) concentrations. Diabetes Care 1997; 20:1242-7
-
(1997)
Diabetes Care
, vol.20
, pp. 1242-1247
-
-
Inoue, K.1
Nago, N.2
Matsuo, H.3
-
29
-
-
0028906523
-
Insulin sensitivity and lipoprotein(a) concentrations in normoglycemic men
-
Haffner SM, Karhapaa P, Rainwater DL, Mykkanen L, Aldrete G Jr, Laakso M: Insulin sensitivity and lipoprotein(a) concentrations in normoglycemic men. Diabetes Care 1995; 18:193-9
-
(1995)
Diabetes Care
, vol.18
, pp. 193-199
-
-
Haffner, S.M.1
Karhapaa, P.2
Rainwater, D.L.3
Mykkanen, L.4
Aldrete Jr., G.5
Laakso, M.6
-
30
-
-
0031814605
-
Insulin and 2-hour glucose levels are inversely related to Lp(a) concentrations controlled for LPA genotype
-
Rainwater DL, Haffner SM: Insulin and 2-hour glucose levels are inversely related to Lp(a) concentrations controlled for LPA genotype. Arterioscler Thromb Vasc Biol 1998; 18:1335-41
-
(1998)
Arterioscler Thromb Vasc Biol
, vol.18
, pp. 1335-1341
-
-
Rainwater, D.L.1
Haffner, S.M.2
-
31
-
-
0038165072
-
The relationship between lipoprotein(a) and the complications of diabetes mellitus
-
Koschinsky ML, Marcovina SM: The relationship between lipoprotein(a) and the complications of diabetes mellitus. Acta Diabetol 2003; 40:65-76
-
(2003)
Acta Diabetol
, vol.40
, pp. 65-76
-
-
Koschinsky, M.L.1
Marcovina, S.M.2
-
32
-
-
0032933140
-
Insulin suppresses apolipoprotein(a) synthesis by primary cultures of cynomolgus monkey hepatocytes
-
Neele DM, de Eit EC, Princen HM: Insulin suppresses apolipoprotein(a) synthesis by primary cultures of cynomolgus monkey hepatocytes. Diabetologia 1999; 42:897-8
-
(1999)
Diabetologia
, vol.42
, pp. 897-898
-
-
Neele, D.M.1
De Eit, E.C.2
Princen, H.M.3
-
33
-
-
0032928201
-
Lipoprotein (a) level in the population in Taiwan: Relationship to sociodemographic and atherosclerotic risk factors
-
Chien K-L, Lee Y-T, Sung F-C, Su T-C, Hsu H-C, Lin R-S. Lipoprotein (a) level in the population in Taiwan: relationship to sociodemographic and atherosclerotic risk factors. Atherosclerosis 1999; 143:267-73
-
(1999)
Atherosclerosis
, vol.143
, pp. 267-273
-
-
Chien, K.-L.1
Lee, Y.-T.2
Sung, F.-C.3
Su, T.-C.4
Hsu, H.-C.5
Lin, R.-S.6
-
34
-
-
0031729386
-
Lipoprotein (a) as a risk factor for ischemic heart disease: Metaanalysis of prospective studies
-
Craig WY, Neveux LM, Palomaki GE, Clevelang MM, Haddow JE: Lipoprotein (a) as a risk factor for ischemic heart disease: metaanalysis of prospective studies. Clin Chem 1998; 11:2301-6
-
(1998)
Clin Chem
, vol.11
, pp. 2301-2306
-
-
Craig, W.Y.1
Neveux, L.M.2
Palomaki, G.E.3
Clevelang, M.M.4
Haddow, J.E.5
-
35
-
-
0030774676
-
Predictive value of electrophoretically detected lipoprotein(a) for coronary heart disease and cerebrovascular disease in a community-based cohort of 9936 men and women
-
Nguyen TT, Ellefson RD, Hodge DO, Bailey KR, Kottke TE, Abu-Lebdeh HS: Predictive value of electrophoretically detected lipoprotein(a) for coronary heart disease and cerebrovascular disease in a community-based cohort of 9936 men and women. Circulation. 1997; 96:1390-7
-
(1997)
Circulation
, vol.96
, pp. 1390-1397
-
-
Nguyen, T.T.1
Ellefson, R.D.2
Hodge, D.O.3
Bailey, K.R.4
Kottke, T.E.5
Abu-Lebdeh, H.S.6
-
36
-
-
0036302220
-
Is lipoprotein(a) a predictor for survival in patients with established coronary artery disease? Results from a prospective patient cohort study in northern Sweden
-
Glader CA, Birgander LS, Stenlund H, Dahlen GH: Is lipoprotein(a) a predictor for survival in patients with established coronary artery disease? Results from a prospective patient cohort study in northern Sweden. J Intern Med. 2002; 252:27-35
-
(2002)
J Intern Med
, vol.252
, pp. 27-35
-
-
Glader, C.A.1
Birgander, L.S.2
Stenlund, H.3
Dahlen, G.H.4
-
37
-
-
0028877052
-
Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein (a)
-
Maher VM, Brown BG, Marcovina SM, Hillger LA, Zhao XQ, Albers JJ: Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein (a). JAMA 1995; 274:1771-4
-
(1995)
JAMA
, vol.274
, pp. 1771-1774
-
-
Maher, V.M.1
Brown, B.G.2
Marcovina, S.M.3
Hillger, L.A.4
Zhao, X.Q.5
Albers, J.J.6
-
38
-
-
0036269884
-
PRIME Study Group: Lipoprotein (a) as a predictor of coronary heart disease: The PRIME Study
-
Luc G, Bard JM, Arveiler D, et al: PRIME Study Group: Lipoprotein (a) as a predictor of coronary heart disease: the PRIME Study. Atherosclerosis. 2002; 163:377-84
-
(2002)
Atherosclerosis
, vol.163
, pp. 377-384
-
-
Luc, G.1
Bard, J.M.2
Arveiler, D.3
-
39
-
-
18144438859
-
Is lipoprotein (a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular Study
-
Cantin B, Gagnon F, Moorjani S, et al: Is lipoprotein (a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular Study. J Am Coll Cardiol 1998; 31:519-25
-
(1998)
J Am Coll Cardiol
, vol.31
, pp. 519-525
-
-
Cantin, B.1
Gagnon, F.2
Moorjani, S.3
|